Qinghai Spring Medicinal Resources Technology Co., Ltd.

SHSE:600381 Stock Report

Market Cap: CN¥1.8b

Qinghai Spring Medicinal Resources Technology Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Xuefeng Zhang

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure9.4yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure4.3yrs

Recent management updates

Recent updates

Qinghai Spring Medicinal Resources Technology Co., Ltd.'s (SHSE:600381) Share Price Is Still Matching Investor Opinion Despite 30% Slump

Jun 24
Qinghai Spring Medicinal Resources Technology Co., Ltd.'s (SHSE:600381) Share Price Is Still Matching Investor Opinion Despite 30% Slump

Qinghai Spring Medicinal Resources Technology Co., Ltd.'s (SHSE:600381) 26% Cheaper Price Remains In Tune With Revenues

May 09
Qinghai Spring Medicinal Resources Technology Co., Ltd.'s (SHSE:600381) 26% Cheaper Price Remains In Tune With Revenues

Qinghai Spring Medicinal Resources Technology Co., Ltd.'s (SHSE:600381) 27% Price Boost Is Out Of Tune With Revenues

Mar 12
Qinghai Spring Medicinal Resources Technology Co., Ltd.'s (SHSE:600381) 27% Price Boost Is Out Of Tune With Revenues

CEO

Xuefeng Zhang (54 yo)

9.4yrs

Tenure

CN¥568,300

Compensation

Mr. Xuefeng Zhang serves as Chairman & GM of Qinghai Spring Medicinal Resources Technology Co., Ltd. since May 15, 2015.


Board Members

NamePositionTenureCompensationOwnership
Xuefeng Zhang
Chairman & GM9.4yrsCN¥568.30kno data
Xuemin Gao
Independent Director4.3yrsCN¥60.00kno data
Jin Zhang
Supervisor2.4yrsno datano data

4.3yrs

Average Tenure

Experienced Board: 600381's board of directors are considered experienced (4.3 years average tenure).